Nxstage Medical Inc
(NXTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 66,873 | 65,462 | 61,644 | 65,020 | 61,152 |
| Cost of Goods | 41,345 | 40,375 | 37,644 | 39,661 | 37,404 |
| Gross Profit | 25,528 | 25,087 | 24,000 | 25,359 | 23,748 |
| Operating Expenses | 30,286 | 29,733 | 29,180 | 27,930 | 26,498 |
| Operating Income | -4,413 | -4,271 | -4,536 | -1,910 | -2,346 |
| Interest Expense | 162 | 150 | 150 | 91 | 26 |
| Other Income | -142 | -10 | -176 | -30 | 13 |
| Pre-tax Income | -4,717 | -4,431 | -4,862 | -2,031 | -2,359 |
| Income Tax | 269 | -1,026 | 132 | 333 | 223 |
| Net Income Continuous | -4,986 | -3,405 | -4,994 | -2,364 | -2,582 |
| Net Income | $-4,986 | $-3,405 | $-4,994 | $-2,364 | $-2,582 |
| EPS Basic Total Ops | -0.08 | -0.06 | -0.08 | -0.04 | -0.04 |
| EPS Basic Continuous Ops | -0.08 | -0.06 | -0.08 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.08 | -0.06 | -0.08 | -0.04 | -0.04 |
| EPS Diluted Continuous Ops | -0.08 | -0.06 | -0.08 | -0.04 | -0.04 |
| EBITDA(a) | $1,758 | $1,908 | $1,544 | $4,268 | $3,569 |